Berman Howard — SEC Form 4 filings

SEC reporting owner CIK 1952986. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-02 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Coya Therapeutics, Inc. (COYA)Executive Chairman, Director44
Atea Pharmaceuticals, Inc. (AVIR)Director23

Form 4 filings — Berman Howard

FiledFormIssuerReported transactionsSource
2026-06-234Atea Pharmaceuticals, Inc. (AVIR)Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-01-264Coya Therapeutics, Inc. (COYA)Grant/award (A): 15,257 (derivative) @ $0EDGAR
2025-06-244Atea Pharmaceuticals, Inc. (AVIR)Grant/award (A): 164,800 (derivative) @ $0EDGAR
2025-01-134Coya Therapeutics, Inc. (COYA)Grant/award (A): 150,602 (derivative) @ $0EDGAR
2024-06-054Coya Therapeutics, Inc. (COYA)Grant/award (A): 163,663 (derivative) @ $0EDGAR
2024-02-024Coya Therapeutics, Inc. (COYA)Grant/award (A): 189,680 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1952986 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →